S. Piano

发表

M. Tonon, S. Piano, 2020, Clinical and molecular hepatology.

Epidemiology, predictors and outcomes of multi drug resistant bacterial infections in patients with cirrhosis across the world. Final results of the “Global study”

H. Kim, Varinder Singh, D. J. Kim, 2018 .

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites.

A. Gasbarrini, A. Andrealli, P. Angeli, 2020, Journal of hepatology.

Including Relative Adrenal Insufficiency in Definition and Classification of Acute on Chronic Liver Failure.

P. Angeli, C. Scaroni, M. Plebani, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

REPLY:

P. Angeli, S. Piano, 2021, Hepatology.

Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome

P. Angeli, P. Burra, U. Cillo, 2020, Hepatology.

Ascites, Hyponatremia, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome

P. Angeli, M. Tonon, S. Piano, 2019, Evidence-based Gastroenterology and Hepatology 4e.

Management of ascites and hepatorenal syndrome

P. Angeli, M. Tonon, S. Piano, 2018, Hepatology International.

P. Angeli, S. Piano, M. Cavallin, 2016, Hepatology.

Outpatients use of terlipressin for hepatorenal syndrome: Not for all, with caution and a wise liver transplant allocation policy

P. Angeli, S. Piano, M. Cavallin, 2015 .

Predicting Outcomes of Liver Transplantation in Patients With Nonalcoholic Steatohepatitis: Pretransplant Renal Function Is Key

P. Angeli, M. Tonon, S. Piano, 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Spontaneous Bacterial Peritonitis in Patients with Cirrhosis and Ascites

P. Angeli, S. Piano, F. Morando, 2011 .

Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?

P. Angeli, A. Gatta, S. Fasolato, 2011, Journal of hepatology.

Performance of non-invasive respiratory function indices in predicting clinical outcomes in patients hospitalized for COVID-19 pneumonia in medical and sub-intensive wards: a retrospective cohort study

G. Parati, M. Montagnana, S. Vicini, 2022, Internal and Emergency Medicine.

Effects of a reorganization of cirrhosis care during the lockdown for SARS-CoV-2 outbreak

P. Pontisso, P. Angeli, M. Marzioni, 2021, JHEP Reports.

Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real‐life cross‐sectional study

P. Angeli, L. Caregaro, A. Gatta, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.

R. Andrade, P. Kamath, J. Trebicka, 2019, The lancet. Gastroenterology & hepatology.

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II TRIAL ASSESSING SAFETY OF TWO DIFFERENT DOSES OF SIMVASTATIN IN COMBINATION WITH RIFAXIMIN IN DECOMPENSATED CIRRHOSIS

R. Andrade, M. Bernardi, P. Kamath, 2019 .

Ginès P. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis

R. Andrade, M. Bernardi, P. Kamath, 2022 .

Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis

A. de Gottardi, T. Sauerbruch, R. Moreau, 2019, Front. Immunol..

Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI)

A. Gasbarrini, W. Ageno, D. Girelli, 2021, Internal and Emergency Medicine.

Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference.

A. Andriulli, E. Grandone, P. Rebulla, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

H. D. de Koning, F. Lammert, T. Karlsen, 2022, BMC Public Health.

Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir

P. Pontisso, P. Angeli, S. Fasolato, 2018, European journal of gastroenterology & hepatology.

Changes in the epidemiology and management of bacterial infections in cirrhosis

P. Angeli, M. Tonon, S. Piano, 2021, Clinical and molecular hepatology.

Bacterial Infections in Cirrhosis

P. Angeli, M. Tonon, S. Piano, 2021, Infectious Microbes and Diseases.

Long-term albumin administration improves survival in patients with decompensated cirrhosis: final results of the “ANSWER” study

A. Gasbarrini, E. Neri, G. Marín, 2017 .

Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome

P. Angeli, M. Tonon, S. Piano, 2019, Critical Care Nephrology.

Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).

S. Moestrup, H. Møller, V. Arroyo, 2016, Journal of hepatology.

Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute‐on‐Chronic Liver Failure

P. Angeli, P. Ginès, Javier Fernández, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes

M. Morales-Ruiz, P. Sancho-Bru, P. Ginès, 2017, Scientific Reports.

Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms

P. Angeli, G. Ceolotto, A. Gatta, 2013, Hepatology.

Tocilizumab for severe COVID-19 pneumonia

C. Sensi, A. Gabrielli, P. Angeli, 2020, The Lancet Rheumatology.

Location and allocation: Inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe

P. Cortesi, R. Fumagalli, K. Zieniewicz, 2022, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine?

A. Frigo, P. Angeli, A. Gatta, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.

B. Colsch, C. Junot, F. Nevens, 2019, Journal of hepatology.

Long‐term administration of human albumin improves survival in patients with cirrhosis and refractory ascites

P. Angeli, S. Fasolato, M. Bolognesi, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Management of bacterial and fungal infections in cirrhosis: The MDRO challenge.

Javier Fernández, M. Bartoletti, S. Piano, 2021, Journal of hepatology.

Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List

G. Crespo, S. Marciano, A. Gadano, 2020, Transplantation.

The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology (120/120).

M. Manns, C. Trautwein, T. Berg, 2020, Journal of hepatology.

Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience.

P. Angeli, P. Ginès, A. Cárdenas, 2017, The American journal of medicine.

P. Angeli, S. Piano, 2016, Hepatology.

Echinocandins versus fluconazole in the treatment of spontaneous fungal peritonitis

P. Angeli, S. Piano, 2016 .

Reply to: "To close the stable door before the horse has bolted".

P. Angeli, S. Piano, F. Morando, 2014, Journal of hepatology.

Current Concepts on Bacterial and Fungal Infections in Cirrhosis

P. Angeli, S. Piano, 2019, Clinical liver disease.

The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial

G. Palù, A. Loregian, P. Angeli, 2016, Hepatology.

Reply.

P. Angeli, S. Piano, 2020, Clinical Gastroenterology and Hepatology.

Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge

P. Angeli, A. Gatta, S. Piano, 2012, European journal of gastroenterology & hepatology.

Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort

G. Gerosa, P. Boffetta, L. Potena, 2022, Microorganisms.

Identifying the four shades of acute decompensation of cirrhosis.

S. Piano, C. Gambino, 2021, United European gastroenterology journal.

Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure.

D. J. Kim, L. Lesmana, R. Maiwall, 2020, Journal of hepatology.

Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis.

P. Angeli, A. Sticca, M. Bolognesi, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome

F. Nevens, J. Trebicka, A. Gerbes, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study

A. Frigo, P. Angeli, S. Fasolato, 2016, Hepatology.

The Treatment of Hepatorenal Syndrome

P. Angeli, S. Fasolato, S. Marenco, 2015, Digestive Diseases.

Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis.

P. Angeli, P. Simioni, G. Rossitto, 2014, European journal of gastroenterology & hepatology.

Diagnosis and management of acute kidney injury in patients with cirrhosis : Revised consensus recommendations of the International Club of Ascites q

W. Kim, S. Sarin, R. Moreau, 2015 .

Dopamine and Furosemide for the Treatment of Hepatorenal Syndrome: A Reappraisal or Just Smoke and Mirrors?

P. Angeli, S. Piano, 2015, Journal of clinical and experimental hepatology.

Hepatorenal syndrome.

P. Angeli, S. Piano, M. Cavallin, 2011, Contributions to nephrology.

Assessment of alcohol consumption in liver transplant candidates and recipients: The best combination of the tools available

P. Angeli, M. Plebani, A. Gatta, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Metabolomics to Predict Acute Kidney Injury in Cirrhosis

A. Cárdenas, S. Piano, 2021, Hepatology.

An Integrated Review of the Hepatorenal Syndrome.

G. Castro-Narro, E. Cerda-Reyes, S. Piano, 2020, Annals of hepatology.

F-50 Increased urinary level of neutrophil gelatinase–associated lipocalin (NGAL) in patients with cirrhosis and type 1 HRS

P. Angeli, A. Gatta, S. Fasolato, 2012 .

The liver: another organ involved in Muir Torre syndrome?

A. Gatta, C. Mescoli, M. Alaibac, 2012, Familial Cancer.

Brexit from current guideline recommendations?

V. Arroyo, P. Angeli, S. Piano, 2016, Gut.

Bacterial or fungal infections in patients with cirrhosis: epidemiology across the world, definition of sepsis and predictors of post discharge outcomes

S. Piano, 2018 .

ENDPOINTS AND DESIGN OF CLINICAL TRIALS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: POSITION PAPER OF THE LIVERHOPE CONSORTIUM.

G. Nicolao, A. Forner, P. Kamath, 2020, Journal of hepatology.

Baveno VII - Renewing consensus in portal hypertension.

H. Yoshiji, J. Fallowfield, V. Paradis, 2021, Journal of hepatology.

Affective and Psychiatric Disorders in Celiac Disease

E. Capristo, G. Gasbarrini, G. Addolorato, 2008, Digestive Diseases.

Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification

A. Frigo, P. Angeli, S. Piano, 2021, Clinical and experimental hepatology.

Immune thrombocytopenic purpura and Kaposi’s sarcoma in a liver transplant recipient

P. Angeli, A. Gatta, S. Piano, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Comparison of fondaparinux and low molecular weight heparin in the treatment of portal vein thrombosis in cirrhosis.

P. Angeli, P. Simioni, M. Senzolo, 2021, The American journal of medicine.

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis

Mark M. Davis, P. Kamath, J. Trebicka, 2021, Hepatology communications.

Italian association for the study of the liver position statement on SARS-CoV2 vaccination

R. Bruno, F. Ponziani, P. Burra, 2021, Digestive and Liver Disease.

Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.

W. Jiménez, M. Morales-Ruiz, P. Ginès, 2021, Journal of hepatology.

Renal Function in Cirrhosis: A Critical Review of Available Tools

P. Angeli, S. Piano, A. Brocca, 2018, Seminars in Liver Disease.

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.

H. Van Vlierberghe, S. Sarin, D. J. Kim, 2019, Gastroenterology.

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event

M. Trauner, M. Mandorfer, T. Reiberger, 2022, JHEP reports : innovation in hepatology.

Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

Ezio Fornasiere, Manuela Merli, Mauro Bernardi, 2015, Hepatology.

Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences.

M. Tonon, S. Piano, 2023, The Medical clinics of North America.

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

A. Gasbarrini, A. Andrealli, P. Angeli, 2018, The Lancet.

The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated cirrhosis: Results of a randomized controlled clinical trial

P. Angeli, A. Gatta, M. Senzolo, 2015 .

Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites

W. Kim, S. Sarin, R. Moreau, 2015, Gut.

Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis

A. Gerbes, M. Pavesi, V. Arroyo, 2014, Gut.

Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS).

P. Cortesi, R. Fumagalli, K. Zieniewicz, 2021, Journal of hepatology.

How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists.

A. Frigo, P. Angeli, A. Gatta, 2013, Journal of hepatology.

Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections

A. Frigo, P. Angeli, P. Caraceni, 2017, Gut.

Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis

P. Angeli, C. Fabris, E. Falleti, 2019, European journal of gastroenterology & hepatology.

Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.

A. de Gottardi, M. Papp, R. Jalan, 2019, Journal of hepatology.

Acute-on-Chronic Liver Failure in Cirrhosis

P. Angeli, S. Piano, C. Gambino, 2021, Journal of clinical medicine.

Neutrophil Gelatinase‐Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study

W. Jiménez, M. Morales-Ruiz, E. Poch, 2019, Hepatology.

Natural history of acute kidney disease in patients with cirrhosis.

P. Pontisso, P. Angeli, A. Martini, 2020, Journal of hepatology.

Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites.

A. Frigo, P. Angeli, A. Gatta, 2013, Journal of hepatology.

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

C. Trautwein, T. Berg, C. Junot, 2023, Gut.

Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites

W. Kim, S. Sarin, R. Moreau, 2015, Gut.

COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study

R. Facchetti, P. Cortesi, K. Zieniewicz, 2021, Gut.

Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections

P. Angeli, G. Carretta, D. Donato, 2017, The American Journal of Gastroenterology.

Liver transplantation in the patient with physical frailty.

J. Heimbach, P. Tandon, S. Dasarathy, 2023, Journal of hepatology.

Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis.

P. Angeli, S. Fasolato, A. Sticca, 2017, Journal of hepatology.

Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation?

P. Angeli, S. Piano, 2021, Clinics in liver disease.

Infections complicating cirrhosis

P. Angeli, S. Piano, A. Brocca, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Bacterial Infections in Acute on Chronic Liver Failure.

P. Angeli, S. Piano, S. Incicco, 2023, Clinics in liver disease.

Impact of bacterial infections prior liver transplantation on post-transplant outcomes in patients with cirrhosis

U. Cillo, M. Tonon, S. Piano, 2022, Digestive and Liver Disease.

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.

M. Manns, C. Trautwein, T. Berg, 2020, Journal of hepatology.

Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study.

P. Angeli, M. Bassetti, P. Caraceni, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Diagnostic and prognostic performance of urinary neutrophil gelatinase‐associated lipocalin in patients with cirrhosis and acute kidney injury

P. Angeli, C. Cosma, D. Basso, 2022, Hepatology.

O093 : The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis : Results of a randomized controlled clinical trial

P. Angeli, A. Gatta, M. Senzolo, 2015 .

Application of the Acute Kidney Injury Network Criteria in Patients with Cirrhosis and Ascites: Benefits and Limitations

P. Angeli, M. Tonon, S. Piano, 2015 .

Acute Kidney Injury and Hepatorenal Syndrome

P. Angeli, S. Piano, 2019, Critical Care for Potential Liver Transplant Candidates.

P. Angeli, S. Piano, 2016, Hepatology.

Treatment of nosocomial spontaneous bacterial peritonitis: Philosophy vs Science

P. Angeli, S. Piano, 2016 .

Is type 2 hepatorenal syndrome still a potential indication for treatment with terlipressin and albumin?

P. Angeli, S. Piano, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Pathophysiology and Management of the Hepatorenal Syndrome

P. Angeli, M. Tonon, S. Piano, 2019, Critical Care Nephrology.

Why and how to measure renal function in patients with liver disease

P. Angeli, S. Piano, A. Romano, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Sepsis-induced acute kidney injury in patients with cirrhosis

P. Angeli, M. Tonon, S. Piano, 2015, Hepatology International.

Reply to JHEPAT-D-21-00702 and JHEPAT-D-21-00793.

P. Angeli, F. Wong, S. Piano, 2021, Journal of hepatology.

Long-term albumin administration in patients with cirrhosis and uncomplicated ascites: the use of serum albumin concentration for personalizing treatment

P. Angeli, G. Svegliati-Baroni, F. Foschi, 2019, Digestive and Liver Disease.

Low myocardial mechano-energetic efficiency is an independent predictor of prognosis in advanced chronic liver disease

A. Frigo, P. Angeli, S. Piano, 2021, European journal of gastroenterology & hepatology.

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

H. D. de Koning, T. Karlsen, G. Pera, 2022, BMC Public Health.

Abnormal liver function tests predict transfer to intensive care unit and death in COVID‐19

P. Angeli, R. Vettor, L. Cerruti, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Hyponatremia and other electrolyte/ion disorders

P. Angeli, S. Piano, F. Morando, 2015 .

Correction and Prevention of Hyponatremia in Patients With Cirrhosis and Ascites: Post Hoc Analysis of the ANSWER Study Database

F. Foschi, P. Caraceni, S. Neri, 2022, The American journal of gastroenterology.

Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort

J. Hasenauer, G. Gerosa, L. Potena, 2023, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.

A. de Gottardi, M. Papp, R. Jalan, 2019, Journal of hepatology.

Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

V. Wong, T. Karlsen, G. Pera, 2023, The Lancet.

Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective.

A. Allegretti, S. Piano, Kavish R. Patidar, 2023, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Impact of bacterial infections prior to liver transplantation on post-transplant outcomes in patients with cirrhosis

P. Angeli, P. Burra, U. Cillo, 2023, JHEP reports : innovation in hepatology.

Incidence, predictors and outcomes of acute on chronic liver failure in outpatients with cirrhosis

P. Angeli, S. Fasolato, A. Sticca, 2016 .

Acute on chronic liver failure in cirrhosis

M. Tonon, S. Piano, 2022, Clinical and molecular hepatology.

Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites

W. Kim, S. Sarin, R. Jalan, 2015, Gut.

Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites.

A. Frigo, P. Angeli, A. Gatta, 2013, Journal of hepatology.

Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be".

P. Angeli, S. Fasolato, M. Tonon, 2015, Journal of hepatology.